Upharmacia January 2017 (Special Edition) | Page 18

Upharmacia January 2017
manufacture substances in the country yet.
• In 11M2016, Russian market of drugs against tobacco dependence increased 15% PPG in values to
RUB 2471.7 m. Currently, there are three OTC brands and one Rx brand presented on the market.
Russian Prime Minister approved the new List of vital and essential drugs for 2017, which included
646 INNs. The Vice Prime Minister stated that, in 2017, the List of essential and vital drugs will be
approved not once, but as new drugs are appearing.
• Rafarma company plans to launch its production onto the market of South Korea. The first supplies
of ceftriaxone are expected to start in 2018.
•
U zbekistan
•
The President of Uzbekistan issue the Order on development of four
pharmaceutical industrial zones: Boysun-pharm (Surxondaryo Region), Buston-
lik-pharm (Tashkent Region), Zaamin-pharm (Jizzakh Region), Syrdarya-pharm
(Sirdaryo Region). The investors will be exempt from land tax, income tax,
property tax of legal entities, etc. for 3-10 years.
18
www.upharma-c.com